SOPHiA GENETICS (SOPH) Cash from Investing Activities (2020 - 2025)

SOPHiA GENETICS's Cash from Investing Activities history runs 6 years deep, the most recent figure standing at -$3.5 million for Q4 2025.

• In Q4 2025, Cash from Investing Activities fell 178.02% year-over-year to -$3.5 million; the TTM figure through Dec 2025 stood at -$8.7 million (down 82.33% YoY), while the FY2025 annual figure was -$8.7 million, down 82.33% from the prior year.
• Cash from Investing Activities came in at -$3.5 million for Q4 2025 at SOPHiA GENETICS, down from -$2.6 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $18.0 million in Q2 2022 to a low of -$52.7 million in Q3 2021.
• A 5-year average of -$770550.0 and a median of -$1.2 million in 2024 frame the typical range for Cash from Investing Activities.
• Across the five-year window, Cash from Investing Activities tumbled 7238.58% in 2021 and surged 1044.1% in 2022, its largest moves.
• SOPHiA GENETICS's Cash from Investing Activities stood at -$1.3 million in 2021, then jumped by 1043.12% to $12.1 million in 2022, then sank by 80.18% to $2.4 million in 2023, then tumbled by 152.37% to -$1.3 million in 2024, then plunged by 178.02% to -$3.5 million in 2025.
• According to Business Quant data, Cash from Investing Activities over the past three periods registered -$3.5 million, -$2.6 million, and -$1.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison